Skip to content
OpenCapital
Get started

Bausch Health Companies BHC Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

PBH
Prestige Consumer HealthcarePBH
$456K+4.1%
Bausch + Lomb logo
Bausch + LombBLCO
$3M-40.0%
HRO
HarrowHROW
$451K-64.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$358K+10.5%
TG Therapeutics logo
TG TherapeuticsTGTX
$285K-6.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.38M-3.8%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%—
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%—
Debt / equity45.2×—
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's debt issuance cost amortization?
Bausch Health Companies (BHC) reported debt issuance cost amortization of $14M in Q1 2026.
How has Bausch Health Companies's debt issuance cost amortization changed year-over-year?
Bausch Health Companies's debt issuance cost amortization decreased by 6.7% year-over-year, from $15M to $14M.
What is the long-term trend for Bausch Health Companies's debt issuance cost amortization?
Over 4 years (2021 to 2025), Bausch Health Companies's debt issuance cost amortization has grown at a 14.3% compound annual growth rate (CAGR), from $55M to $94M.
What does debt issuance cost amortization mean?
Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).